Directional Preference Exercises in Comparison to Motor Control Exercises in Mechanical Low Back Pain

Sponsor
Foundation University Islamabad (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05691907
Collaborator
(none)
40
2
2
22
20
0.9

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effects Of Directional Preference Exercises in Comparison to Motor Control Exercises in Patients With Mechanical Low Back Pain

Condition or Disease Intervention/Treatment Phase
  • Device: THE therapy
  • Procedure: Directional Preference Exercises
  • Procedure: Motor Control Exercises
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects Of Directional Preference Exercises in Comparison to Motor Control Exercises in Patients With Mechanical Low Back Pain
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Directional Preference Exercises

Directional Preference Exercises will be provided, also known as Mckenzie's extension exercises

Device: THE therapy
THE therapy consisting of: Heating Pad Interferential Therapy

Procedure: Directional Preference Exercises
Directional Preference Exercises consisting of Mckenzie's extension protocol

Experimental: Motor Control Exercises

Motor Control Exercises consisting of extension bias external limb loading protocol.

Device: THE therapy
THE therapy consisting of: Heating Pad Interferential Therapy

Procedure: Motor Control Exercises
Motor Control Exercises consisting of External limb loading extension protocol

Outcome Measures

Primary Outcome Measures

  1. Back Pain [2 week]

    Pain will be measured using Numeric Pain Rating Scale, on a scale of 1 to 10. higher scores represent poorer outcome.

  2. Disability [2 week]

    Disability will be measured using Roland Morris Disability Questionnaire. Higher scores represent poorer outcome.

  3. Range of Motion [2 week]

    Range of Motion will be measured using inclinometer. Higher scores represent better outcome.

  4. Sleep Quality [2 week]

    Sleep Quality will be measured using Pittsburg Sleep Quality Index. Higher scores represent poorer outcome.

  5. Postural Stability Index [2 week]

    Postural Stability Index will be measured using Biodex Balance System. Higher scores represent poorer outcome.

  6. Real time Physical Activity [2 week]

    Real time Physical Activity will be measured using wearable sensor technology. Higher scores represent better outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Both male & Female patients

  • Age group 20-60 Years

  • Diagnosed with mechanical low back pain having pain aggravation in flexion bias

Exclusion Criteria:
  • Lumbar stenosis

  • Cauda Equina

  • Spondylolisthesis

  • Ankylosing Spondylitis

  • Scoliosis

  • Leg Length Discrepancy

  • Muscular Dystrophy

  • Low back pain from non-musculoskeletal causes

  • Fracture or traumatic low back pain

  • Any infection, tumor, spinal surgery, cognitive impairments, or any other rheumatologic disease would be excluded

Contacts and Locations

Locations

Site City State Country Postal Code
1 Foundation University Islamabad Pakistan
2 Kulsum International Hospital Islamabad Pakistan

Sponsors and Collaborators

  • Foundation University Islamabad

Investigators

  • Principal Investigator: Muhammad Osama, PhD*, FUI

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Foundation University Islamabad
ClinicalTrials.gov Identifier:
NCT05691907
Other Study ID Numbers:
  • FUI/CTR/2023/2
First Posted:
Jan 20, 2023
Last Update Posted:
Jan 20, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 20, 2023